Form 4: Neuraxis Executive Receives Stock Grant
Insider Transaction (Form 4)
Adrian Miranda, CMO, SVP Science & Tech of Neuraxis, INC, reported multiple transactions in common stock on August 24, 2026.
Summary
- Grant/award: acquired 199,106 Common Stock on August 24, 2026; holds 199,106 after (Direct).
- Conversion of derivative: disposed of 337,204 Stock Options at $6.94 ($2,340,196) on August 24, 2026 (Direct).
- Grant/award: acquired 337,204 RSU on August 24, 2026; holds 337,204 after (Direct).
- Conversion of derivative: disposed of 337,204 RSU on August 24, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Adrian Miranda — Officer (CMO, SVP Science & Tech)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Grant/award | Common Stock | 199,106 | — | — | 199,106 |
| 2026-08-24 | Conversion of derivative | Stock Options | 337,204 | $7 | $2.3M | 0 |
| 2026-08-24 | Grant/award | RSU | 337,204 | — | — | 337,204 |
| 2026-08-24 | Conversion of derivative | RSU | 337,204 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Grant/award (199,106 shares) |
| 2026-08-24 | Conversion of derivative (337,204 shares) |
| 2026-08-24 | Grant/award (337,204 shares) |
| 2026-08-24 | Conversion of derivative (337,204 shares) |
Keywords
insider transaction, Form 4, NRXS, Neuraxis, INC, neutral, Adrian Miranda
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.